{"id":75988,"date":"2026-10-06T19:54:25","date_gmt":"2026-10-06T19:54:25","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=75988"},"modified":"2026-10-06T19:54:25","modified_gmt":"2026-10-06T19:54:25","slug":"u-s-analyst-updates-october-6th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/","title":{"rendered":"U.S. Analyst Updates: October 6th, 2026"},"content":{"rendered":"<h2><a href=\"https:\/\/www.stocktargetadvisor.com\/blog\/?p=75988&amp;preview=true\">Analyst Ratings (USA)<\/a><\/h2>\n<p>Today\u2019s U.S. analyst updates suggest a selectively bullish but uneven outlook, with higher targets across semiconductors, AI infrastructure and selected software businesses. Financials remain mixed, as regional-bank upgrades contrast with target reductions across insurers, brokers and consumer lenders. Housing, automotive retail and transportation show greater caution through target cuts and some Sell initiations, while healthcare, defence, copper and refining attract selective support. Overall, analysts continue to favour specific growth opportunities while trimming expectations across several economically sensitive sectors.<\/p>\n<h3><strong>Updates (364)<\/strong><\/h3>\n<p>4D Molecular Therapeutics (FDMT) \u2014 Chardan Capital maintained its Buy rating and lowered its price target to $25.00 from $26.00.<\/p>\n<p>AbbVie (ABBV) \u2014 Scotiabank maintained its Sector Outperform rating and raised its price target to $320.00 from $280.00.<\/p>\n<p>AbbVie (ABBV) \u2014 UBS reiterated its Neutral rating.<\/p>\n<p>Acadia Healthcare (ACHC) \u2014 Cantor Fitzgerald reiterated its Neutral rating.<\/p>\n<p>Accenture (ACN) \u2014 Mizuho maintained its Outperform rating and raised its price target to $241.00 from $226.00.<\/p>\n<p>Advance Auto Parts (AAP) \u2014 Evercore set a price target of $45.00; no rating was supplied.<\/p>\n<p>Advanced Drainage Systems (WMS) \u2014 DA Davidson reiterated its Buy rating and a $190.00 price target.<\/p>\n<p>Advanced Micro Devices (AMD) \u2014 Citigroup maintained its Buy rating and raised its price target to $800.00 from $575.00.<\/p>\n<p>Advanced Micro Devices (AMD) \u2014 Mizuho maintained its Outperform rating and raised its price target to $705.00 from $580.00.<\/p>\n<p>AeroVironment (AVAV) \u2014 Rothschild &amp; Co Redburn initiated coverage with a Neutral rating and a $165.00 price target.<\/p>\n<p>Affirm (AFRM) \u2014 TD Cowen maintained its Buy rating and lowered its price target to $110.00 from $124.00.<\/p>\n<p>Aflac (AFL) \u2014 UBS maintained its Neutral rating and raised its price target to $125.00 from $124.00.<\/p>\n<p>Albemarle (ALB) \u2014 BMO Capital Markets reiterated its Outperform rating and a $175.00 price target.<\/p>\n<p>Alector (ALEC) \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to $3.00 from $2.00.<\/p>\n<p>Alector (ALEC) \u2014 UBS reiterated its Neutral rating and a $1.50 price target.<\/p>\n<p>Alignment Healthcare (ALHC) \u2014 Barclays set a price target of $10.00; no rating was supplied.<\/p>\n<p>Allegiant Travel (ALGT) \u2014 Citigroup reiterated its Buy rating.<\/p>\n<p>Allstate (ALL) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $240.00 from $265.00.<\/p>\n<p>Ally Financial (ALLY) \u2014 Goldman Sachs set a price target of $45.00; no rating was supplied.<\/p>\n<p>Ally Financial (ALLY) \u2014 Raymond James maintained its Strong Buy rating and lowered its price target to $52.00 from $55.00.<\/p>\n<p>Ally Financial (ALLY) \u2014 TD Cowen maintained its Buy rating and lowered its price target to $54.00 from $55.00.<\/p>\n<p>Alphabet (GOOG) \u2014 UBS reiterated its Overweight rating.<\/p>\n<p>Alphabet (GOOG\/GOOGL) \u2014 Wells Fargo maintained its Overweight rating and raised its price target to $417.00 from $411.00.<\/p>\n<p>Amazon.com (AMZN) \u2014 Susquehanna reiterated its Positive rating.<\/p>\n<p>Amazon.com (AMZN) \u2014 Tigress Financial maintained its Buy rating and raised its price target to $385.00 from $315.00.<\/p>\n<p>Amentum (AMTM) \u2014 BNP Paribas Exane upgraded its rating to Neutral from Underperform with a $20.00 price target (previous target: $21.00).<\/p>\n<p>American Airlines Group (AAL) \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $14.00 from $17.00.<\/p>\n<p>American Express (AXP) \u2014 TD Cowen maintained its Hold rating and lowered its price target to $335.00 from $338.00.<\/p>\n<p>American Integrity Insurance Group (AII) \u2014 Raymond James reiterated its Outperform rating.<\/p>\n<p>American International Group (AIG) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $80.00 from $81.00.<\/p>\n<p>American International Group (AIG) \u2014 UBS maintained its Buy rating and raised its price target to $100.00 from $98.00.<\/p>\n<p>Ameriprise Financial (AMP) \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $520.00 from $560.00.<\/p>\n<p>Amphenol (APH) \u2014 Goldman Sachs maintained its Buy rating and raised its price target to $116.00 from $102.00.<\/p>\n<p>Anixa Biosciences (ANIX) \u2014 Citigroup reiterated its Buy rating.<\/p>\n<p>Antero Resources (AR) \u2014 UBS maintained its Buy rating and lowered its price target to $54.00 from $58.00.<\/p>\n<p>AON (AON) \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $350.00 from $410.00.<\/p>\n<p>Apple (AAPL) \u2014 UBS reiterated its Neutral rating.<\/p>\n<p>AppLovin (APP) \u2014 Needham reiterated its Buy rating and a $475.00 price target.<\/p>\n<p>Aptiv (APTV) \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to $61.00 from $71.00.<\/p>\n<p>ArcelorMittal (MT) \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $64.00 from $69.00.<\/p>\n<p>Arch Capital Group (ACGL) \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $105.00 from $111.00.<\/p>\n<p>Arthur J. Gallagher &amp; Co. (AJG) \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $260.00 from $285.00.<\/p>\n<p>Asbury Automotive Group (ABG) \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $230.00 from $265.00.<\/p>\n<p>Assurant (AIZ) \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $300.00 from $320.00.<\/p>\n<p>Atmos Energy (ATO) \u2014 Argus reiterated its Buy rating and a $185.00 price target.<\/p>\n<p>AutoNation (AN) \u2014 Barclays maintained its Overweight rating and lowered its price target to $230.00 from $260.00.<\/p>\n<p>AvePoint (AVPT) \u2014 BMO Capital Markets initiated coverage with a Outperform rating and a $17.00 price target.<\/p>\n<p>Banco Bradesco (BBD) \u2014 Bradesco Corretora upgraded its rating to Overweight from Neutral.<\/p>\n<p>Banco De Chile (BCH) \u2014 JPMorgan Chase maintained its Neutral rating and lowered its price target to $44.00 from $45.00.<\/p>\n<p>Banco Santander Chile (BSAC) \u2014 JPMorgan Chase maintained its Overweight rating and lowered its price target to $39.00 from $43.00.<\/p>\n<p>Bank of America (BAC) \u2014 Rothschild &amp; Co Redburn set a price target of $72.00; no rating was supplied.<\/p>\n<p>BankUnited (BKU) \u2014 Raymond James maintained its Outperform rating and lowered its price target to $49.00 from $52.00.<\/p>\n<p>Benitec Biopharma (BNTC) \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p>Better Home &amp; Finance (BETR) \u2014 Needham reiterated its Buy rating and a $25.00 price target.<\/p>\n<p>BioRestorative Therapies (BRTX) \u2014 Maxim Group downgraded its rating to Hold from Buy.<\/p>\n<p>BitMine Immersion Technologies (BMNR) \u2014 Cantor Fitzgerald reiterated its Overweight rating.<\/p>\n<p>BlackRock (BLK) \u2014 JPMorgan Chase maintained its Overweight rating and raised its price target to $1,435.00 from $1,364.00.<\/p>\n<p>Blaize (BZAI) \u2014 Craig Hallum downgraded its rating to Hold.<\/p>\n<p>Booz Allen Hamilton (BAH) \u2014 TD Cowen maintained its Hold rating and raised its price target to $77.00 from $75.00.<\/p>\n<p>BorgWarner (BWA) \u2014 Morgan Stanley upgraded its rating to Overweight from Equal Weight with a $95 price target.<\/p>\n<p>Boston Beer (SAM) \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to $190.00 from $210.00.<\/p>\n<p>Boyd Gaming (BYD) \u2014 Deutsche Bank upgraded its rating to Buy from Hold with a $99.00 price target (previous target: $98.00).<\/p>\n<p>Bread Financial (BFH) \u2014 TD Cowen maintained its Hold rating and lowered its price target to $111.00 from $114.00.<\/p>\n<p>BridgeBio Pharma (BBIO) \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n<p>Brown &amp; Brown (BRO) \u2014 Morgan Stanley maintained its Underweight rating and lowered its price target to $55.00 from $60.00.<\/p>\n<p>Builders FirstSource (BLDR) \u2014 Melius Research initiated coverage with a Sell rating and a $52.00 price target.<\/p>\n<p>BWX Technologies (BWXT) \u2014 Truist Financial maintained its Hold rating and lowered its price target to $182.00 from $202.00.<\/p>\n<p>C.H. Robinson Worldwide (CHRW) \u2014 Bank of America reiterated its Buy rating and a $203.00 price target.<\/p>\n<p>C.H. Robinson Worldwide (CHRW) \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p>C.H. Robinson Worldwide (CHRW) \u2014 Evercore set a price target of $217.00; no rating was supplied.<\/p>\n<p>C.H. Robinson Worldwide (CHRW) \u2014 Jefferies reiterated its Buy rating and a $220.00 price target.<\/p>\n<p>C.H. Robinson Worldwide (CHRW) \u2014 Sanford C. Bernstein reiterated its Market Perform rating.<\/p>\n<p>C.H. Robinson Worldwide (CHRW) \u2014 TD Cowen reiterated its Hold rating.<\/p>\n<p>C.H. Robinson Worldwide (CHRW) \u2014 UBS reiterated its Buy rating.<\/p>\n<p>CACI International (CACI) \u2014 BNP Paribas Exane downgraded its rating to Underperform from Neutral with a $540.00 price target (previous target: $675.00).<\/p>\n<p>Camping World (CWH) \u2014 JPMorgan Chase maintained its Overweight rating and lowered its price target to $9.00 from $11.00.<\/p>\n<p>Capital One Financial (COF) \u2014 TD Cowen maintained its Buy rating and lowered its price target to $242.00 from $253.00.<\/p>\n<p>CareTrust REIT (CTRE) \u2014 KeyCorp reiterated its Overweight rating.<\/p>\n<p>CarGurus (CARG) \u2014 Barclays maintained its Overweight rating and lowered its price target to $38.00 from $41.00.<\/p>\n<p>Carvana (CVNA) \u2014 Barclays maintained its Overweight rating and lowered its price target to $80.00 from $93.00.<\/p>\n<p>Carvana (CVNA) \u2014 Stephens maintained its Overweight rating and lowered its price target to $83.00 from $91.50.<\/p>\n<p>Celsius (CELH) \u2014 Jefferies reiterated its Buy rating and a $42.00 price target.<\/p>\n<p>CGI Group (GIB) \u2014 RBC Capital Markets reiterated its Sector Perform rating and a $100.00 price target.<\/p>\n<p>Chain Bridge Bancorp (CBNA) \u2014 Raymond James upgraded its rating to Outperform from Market Perform with a $53.00 price target.<\/p>\n<p>Cheesecake Factory (CAKE) \u2014 Oppenheimer maintained its Outperform rating and raised its price target to $122.00 from $101.00.<\/p>\n<p>Chord Energy (CHRD) \u2014 UBS maintained its Buy rating and raised its price target to $193.00 from $184.00.<\/p>\n<p>Chubb (CB) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $350.00 from $360.00.<\/p>\n<p>Cleveland-Cliffs (CLF) \u2014 Wells Fargo upgraded its rating to Overweight from Equal Weight with a $14.00 price target (previous target: $12.00).<\/p>\n<p>Cloudflare (NET) \u2014 BTIG Research maintained its Buy rating and raised its price target to $413.00 from $382.00.<\/p>\n<p>CMS Energy (CMS) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $73.00 from $77.00.<\/p>\n<p>CMS Energy (CMS) \u2014 Capital One Financial set a price target of $73.00; no rating was supplied.<\/p>\n<p>CMS Energy (CMS) \u2014 RBC Capital Markets set a price target of $73.00; no rating was supplied.<\/p>\n<p>Commercial Metals (CMC) \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $68.00 from $80.00.<\/p>\n<p>Community Financial System (CBU) \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $65.00 from $71.00.<\/p>\n<p>Compass Minerals International (CMP) \u2014 BMO Capital Markets reiterated its Market Perform rating.<\/p>\n<p>Consolidated Edison (ED) \u2014 Jefferies reiterated its Hold rating and a $105.00 price target.<\/p>\n<p>Corebridge Financial (CRBG) \u2014 UBS maintained its Neutral rating and raised its price target to $36.00 from $32.00.<\/p>\n<p>Corteva (CTVA) \u2014 JPMorgan Chase upgraded its rating to Overweight from Neutral with a $19.00 price target.<\/p>\n<p>CoStar Group (CSGP) \u2014 Needham reiterated its Buy rating and a $40.00 price target.<\/p>\n<p>Credit Acceptance (CACC) \u2014 TD Cowen maintained its Hold rating and lowered its price target to $590.00 from $600.00.<\/p>\n<p>Crescent Biopharma (CBIO) \u2014 H.C. Wainwright upgraded its rating to Buy from Neutral with a $36.00 price target.<\/p>\n<p>D.R. Horton (DHI) \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $130.00 from $141.00.<\/p>\n<p>D.R. Horton (DHI) \u2014 Melius Research initiated coverage with a Sell rating and a $128.00 price target.<\/p>\n<p>Dell Technologies (DELL) \u2014 Mizuho maintained its Outperform rating and raised its price target to $650.00 from $600.00.<\/p>\n<p>Delta Air Lines (DAL) \u2014 UBS reiterated its Buy rating.<\/p>\n<p>Delta Air Lines (DAL) \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $100.00 from $105.00.<\/p>\n<p>Devon Energy (DVN) \u2014 BMO Capital Markets reiterated its Outperform rating and a $67.00 price target.<\/p>\n<p>Diodes (DIOD) \u2014 Bank of America initiated coverage with a Buy rating and a $135.00 price target.<\/p>\n<p>Diodes (DIOD) \u2014 Wells Fargo set a price target of $135.00; no rating was supplied.<\/p>\n<p>Dollar General (DG) \u2014 Gordon Haskett upgraded its rating to Buy from Hold with a $140.00 price target.<\/p>\n<p>DT Midstream (DTM) \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $142.00 from $143.00.<\/p>\n<p>Elmet Group (ELMT) \u2014 Canaccord Genuity Group maintained its Buy rating and raised its price target to $26.00 from $21.00.<\/p>\n<p>Enphase Energy (ENPH) \u2014 Barclays set a price target of $44.00; no rating was supplied.<\/p>\n<p>Envoy Medical (COCH) \u2014 Lake Street initiated coverage with a Buy rating and a $2.50 price target.<\/p>\n<p>Equity Lifestyle Properties (ELS) \u2014 UBS maintained its Buy rating and lowered its price target to $67.00 from $76.00.<\/p>\n<p>Ermenegildo Zegna (ZGN) \u2014 HSBC initiated coverage with a Buy rating and a $16.00 price target.<\/p>\n<p>Expand Energy (EXE) \u2014 Mizuho maintained its Outperform rating and lowered its price target to $138.00 from $145.00.<\/p>\n<p>Expedia Group (EXPE) \u2014 BTIG Research reiterated its Buy rating and a $400.00 price target.<\/p>\n<p>Ferguson (FERG) \u2014 Melius Research initiated coverage with a Hold rating and a $252.00 price target.<\/p>\n<p>Ferrovial (FER) \u2014 JPMorgan Chase downgraded its rating to Neutral from Overweight.<\/p>\n<p>First Bancorp (FBNC) \u2014 Raymond James downgraded its rating to Outperform from Strong Buy with a $71.00 price target (previous target: $72.00).<\/p>\n<p>First Merchants (FRME) \u2014 Raymond James upgraded its rating to Outperform from Market Perform with a $46.00 price target.<\/p>\n<p>FirstCash (FCFS) \u2014 TD Cowen maintained its Buy rating and raised its price target to $242.00 from $240.00.<\/p>\n<p>Flowers Foods (FLO) \u2014 Jefferies set a price target of $6.00; no rating was supplied.<\/p>\n<p>Ford Motor (F) \u2014 Goldman Sachs maintained its Neutral rating and lowered its price target to $14.00 from $16.00.<\/p>\n<p>Fortrea (FTRE) \u2014 Barclays upgraded its rating to Overweight from Equal Weight with a $23.00 price target (previous target: $22.00).<\/p>\n<p>Fortune Brands Innovations (FBIN) \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $47.00 from $54.00.<\/p>\n<p>Fortune Brands Innovations (FBIN) \u2014 Melius Research initiated coverage with a Hold rating and a $44.00 price target.<\/p>\n<p>Four Corners Property Trust (FCPT) \u2014 JPMorgan Chase maintained its Neutral rating and lowered its price target to $26.00 from $29.00.<\/p>\n<p>Freeport-McMoRan (FCX) \u2014 Barclays maintained its Overweight rating and raised its price target to $83.00 from $82.00.<\/p>\n<p>Freeport-McMoRan (FCX) \u2014 Wells Fargo maintained its Overweight rating and raised its price target to $87.00 from $70.00.<\/p>\n<p>Fulton Financial (FULT) \u2014 Raymond James downgraded its rating to Market Perform from Outperform.<\/p>\n<p>General Motors (GM) \u2014 Goldman Sachs maintained its Buy rating and raised its price target to $112.00 from $103.00.<\/p>\n<p>Gentex (GNTX) \u2014 Goldman Sachs downgraded its rating to Sell from Neutral with a $20.00 price target (previous target: $23.00).<\/p>\n<p>Geo Group (GEO) \u2014 JonesTrading reiterated its Buy rating and a $40.00 price target.<\/p>\n<p>Geo Group (GEO) \u2014 UBS reiterated its Buy rating.<\/p>\n<p>Globant (GLOB) \u2014 Mizuho maintained its Outperform rating and lowered its price target to $51.00 from $59.00.<\/p>\n<p>The Goldman Sachs Group (GS) \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $970.00 from $972.00.<\/p>\n<p>Goosehead Insurance (GSHD) \u2014 Piper Sandler downgraded its rating to Neutral from Overweight with a $48.00 price target (previous target: $72.00).<\/p>\n<p>Group 1 Automotive (GPI) \u2014 Barclays maintained its Overweight rating and lowered its price target to $320.00 from $365.00.<\/p>\n<p>Gulfport Energy (GPOR) \u2014 UBS maintained its Buy rating and lowered its price target to $218.00 from $223.00.<\/p>\n<p>Hallador Energy (HNRG) \u2014 Northland Securities set a price target of $27.00; no rating was supplied.<\/p>\n<p>Hamilton Insurance Group (HG) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $35.00 from $37.00.<\/p>\n<p>The Hanover Insurance Group (THG) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $230.00 from $240.00.<\/p>\n<p>The Hartford Insurance Group (HIG) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $135.00 from $145.00.<\/p>\n<p>The Hartford Insurance Group (HIG) \u2014 UBS maintained its Buy rating and lowered its price target to $149.00 from $155.00.<\/p>\n<p>HeartBeam (BEAT) \u2014 H.C. Wainwright reiterated its Neutral rating.<\/p>\n<p>Helen of Troy (HELE) \u2014 Canaccord Genuity Group maintained its Hold rating and raised its price target to $26.00 from $25.00.<\/p>\n<p>Hilltop (HTH) \u2014 Raymond James downgraded its rating to Underperform from Market Perform.<\/p>\n<p>Home Depot (HD) \u2014 Melius Research set a price target of $397.00; no rating was supplied.<\/p>\n<p>Hormel Foods (HRL) \u2014 Piper Sandler reiterated its Neutral rating.<\/p>\n<p>Hub Group (HUBG) \u2014 Wells Fargo maintained its Negative rating and lowered its price target to $28.00 from $35.00.<\/p>\n<p>HubSpot (HUBS) \u2014 Needham reiterated its Buy rating and a $300.00 price target.<\/p>\n<p>HubSpot (HUBS) \u2014 RBC Capital Markets reiterated its Outperform rating.<\/p>\n<p>HubSpot (HUBS) \u2014 William Blair reiterated its Market Perform rating.<\/p>\n<p>HudBay Minerals (HBM) \u2014 Barclays reiterated its Overweight rating.<\/p>\n<p>Huntington Bancshares (HBAN) \u2014 Keefe, Bruyette &amp; Woods maintained its Market Perform rating and lowered its price target to $18.00 from $19.50.<\/p>\n<p>Huntington Bancshares (HBAN) \u2014 UBS set a price target of $18.00; no rating was supplied.<\/p>\n<p>Huntsman (HUN) \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $9.00 from $11.00.<\/p>\n<p>Insmed (INSM) \u2014 BMO Capital Markets reiterated its Outperform rating.<\/p>\n<p>Installed Building Products (IBP) \u2014 Melius Research initiated coverage with a Hold rating and a $217.00 price target.<\/p>\n<p>Intel (INTC) \u2014 Mizuho maintained its Neutral rating and raised its price target to $114.00 from $92.00.<\/p>\n<p>Intellia Therapeutics (NTLA) \u2014 Barclays initiated coverage with a Underweight rating and a $8.00 price target.<\/p>\n<p>Interactive Brokers Group (IBKR) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $105.00 from $110.00.<\/p>\n<p>Interactive Brokers Group (IBKR) \u2014 Capital One Financial set a price target of $105.00; no rating was supplied.<\/p>\n<p>inTEST (INTT) \u2014 Northland Securities set a price target of $17.00; no rating was supplied.<\/p>\n<p>iRhythm Technologies (IRTC) \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $150.00 from $168.00.<\/p>\n<p>James Hardie Industries (JHX) \u2014 Melius Research initiated coverage with a Buy rating and a $36.00 price target.<\/p>\n<p>James Hardie Industries (JHX) \u2014 Raymond James set a price target of $36.00; no rating was supplied.<\/p>\n<p>JetBlue Airways (JBLU) \u2014 Citigroup upgraded its rating to Neutral from Sell with a $4.50 price target (previous target: $5.30).<\/p>\n<p>Johnson &amp; Johnson (JNJ) \u2014 RBC Capital Markets maintained its Outperform rating and raised its price target to $290.00 from $287.00.<\/p>\n<p>JPMorgan Chase &amp; Co. (JPM) \u2014 Barclays reiterated its Overweight rating.<\/p>\n<p>KB Home (KBH) \u2014 Melius Research initiated coverage with a Sell rating and a $43.00 price target.<\/p>\n<p>Keysight Technologies (KEYS) \u2014 Goldman Sachs maintained its Buy rating and raised its price target to $487.00 from $452.00.<\/p>\n<p>Kinsale Capital Group (KNSL) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $350.00 from $390.00.<\/p>\n<p>KLA (KLAC) \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to $227.00 from $253.00.<\/p>\n<p>Klarna Group (KLAR) \u2014 TD Cowen maintained its Hold rating and lowered its price target to $16.00 from $18.00.<\/p>\n<p>Knight-Swift Transportation (KNX) \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $81.00 from $86.00.<\/p>\n<p>Korro Bio (KRRO) \u2014 H.C. Wainwright reiterated its Buy rating and a $15.00 price target.<\/p>\n<p>Korro Bio (KRRO) \u2014 Jefferies set a price target of $15.00; no rating was supplied.<\/p>\n<p>Kratos Defense &amp; Security Solutions (KTOS) \u2014 Rothschild &amp; Co Redburn initiated coverage with a Buy rating and a $70.00 price target.<\/p>\n<p>Landstar System (LSTR) \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $225.00 from $240.00.<\/p>\n<p>Lattice Semiconductor (LSCC) \u2014 William Blair initiated coverage with a Outperform rating.<\/p>\n<p>Lazard (LAZ) \u2014 Capital One Financial set a price target of $38.00; no rating was supplied.<\/p>\n<p>LB Pharmaceuticals (LBRX) \u2014 Guggenheim initiated coverage with a Buy rating and a $80 price target.<\/p>\n<p>Lear (LEA) \u2014 Goldman Sachs maintained its Neutral rating and lowered its price target to $124.00 from $140.00.<\/p>\n<p>Leidos (LDOS) \u2014 Jefferies reiterated its Hold rating and a $130.00 price target.<\/p>\n<p>Leidos (LDOS) \u2014 TD Cowen maintained its Hold rating and lowered its price target to $130.00 from $135.00.<\/p>\n<p>Lemonade (LMND) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $48.00 from $56.00.<\/p>\n<p>Lennar (LEN) \u2014 Melius Research initiated coverage with a Sell rating and a $72.00 price target.<\/p>\n<p>LGI Homes (LGIH) \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p>Lincoln National (LNC) \u2014 UBS maintained its Neutral rating and raised its price target to $46.00 from $44.00.<\/p>\n<p>Lithia Motors (LAD) \u2014 Barclays maintained its Overweight rating and lowered its price target to $375.00 from $415.00.<\/p>\n<p>Lithium Americas (LAC) \u2014 BMO Capital Markets set a price target of $3.50; no rating was supplied.<\/p>\n<p>Lockheed Martin (LMT) \u2014 Rothschild &amp; Co Redburn initiated coverage with a Buy rating and a $650.00 price target.<\/p>\n<p>Louisiana-Pacific (LPX) \u2014 Barclays maintained its Overweight rating and lowered its price target to $88.00 from $92.00.<\/p>\n<p>Lowe&#8217;s Companies (LOW) \u2014 Evercore set a price target of $190.00; no rating was supplied.<\/p>\n<p>Lowe&#8217;s Companies (LOW) \u2014 Melius Research set a price target of $244.00; no rating was supplied.<\/p>\n<p>LPL Financial (LPLA) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $370.00 from $390.00.<\/p>\n<p>LPL Financial (LPLA) \u2014 Capital One Financial set a price target of $370.00; no rating was supplied.<\/p>\n<p>Lucid Group (LCID) \u2014 UBS reiterated its Hold rating.<\/p>\n<p>LuxExperience B.V. (LUXE) \u2014 Sanford C. Bernstein initiated coverage with a Outperform rating and a $12.90 price target.<\/p>\n<p>MapLight Therapeutics (MPLT) \u2014 Guggenheim initiated coverage with a Neutral rating.<\/p>\n<p>Marsh &amp; McLennan Companies (MRSH) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $180.00 from $200.00.<\/p>\n<p>Marsh &amp; McLennan Companies (MRSH) \u2014 UBS maintained its Buy rating and raised its price target to $222.00 from $216.00.<\/p>\n<p>Masco (MAS) \u2014 Melius Research initiated coverage with a Hold rating and a $75.00 price target.<\/p>\n<p>McDonald&#8217;s (MCD) \u2014 KeyCorp maintained its Overweight rating and lowered its price target to $280.00 from $305.00.<\/p>\n<p>McKesson (MCK) \u2014 Morgan Stanley set a price target of $977.00; no rating was supplied.<\/p>\n<p>MercadoLibre (MELI) \u2014 Susquehanna maintained its Positive rating and a $2,400.00 price target.<\/p>\n<p>Meritage Homes (MTH) \u2014 Melius Research initiated coverage with a Sell rating and a $59.00 price target.<\/p>\n<p>Meta Platforms (META) \u2014 Wells Fargo maintained its Overweight rating and raised its price target to $1,000.00 from $796.00.<\/p>\n<p>MetLife (MET) \u2014 UBS maintained its Buy rating and raised its price target to $110.00 from $105.00.<\/p>\n<p>Mobileye Global (MBLY) \u2014 Goldman Sachs maintained its Neutral rating and lowered its price target to $8.00 from $9.00.<\/p>\n<p>Modine Manufacturing (MOD) \u2014 Robert W. Baird initiated coverage with a Outperform rating and a $300.00 price target.<\/p>\n<p>Mohawk Industries (MHK) \u2014 Melius Research initiated coverage with a Buy rating and a $188.00 price target.<\/p>\n<p>Morgan Stanley (MS) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $215.00 from $250.00.<\/p>\n<p>MYR Group (MYRG) \u2014 Jefferies upgraded its rating to Buy from Hold with a $370.00 price target (previous target: $377.00).<\/p>\n<p>Natera (NTRA) \u2014 Citigroup maintained its Buy rating and raised its price target to $480.00 from $365.00.<\/p>\n<p>Nelnet (NNI) \u2014 TD Cowen maintained its Hold rating and lowered its price target to $125.00 from $130.00.<\/p>\n<p>NeoGenomics (NEO) \u2014 BTIG Research upgraded its rating to Buy from Neutral with a $28 price target.<\/p>\n<p>NeoGenomics (NEO) \u2014 Needham maintained its Buy rating and raised its price target to $22.00 from $19.00.<\/p>\n<p>NetApp (NTAP) \u2014 TD Cowen maintained its Buy rating and raised its price target to $250.00 from $200.00.<\/p>\n<p>Netflix (NFLX) \u2014 Goldman Sachs reiterated its Buy rating and a $90.00 price target.<\/p>\n<p>Netskope (NTSK) \u2014 BTIG Research maintained its Buy rating and raised its price target to $22.00 from $18.00.<\/p>\n<p>Neurocrine Biosciences (NBIX) \u2014 Guggenheim resumed coverage with a Buy rating and a $207.00 price target.<\/p>\n<p>NextEra Energy (NEE) \u2014 Mizuho maintained its Neutral rating and lowered its price target to $80.00 from $95.00.<\/p>\n<p>NIKE (NKE) \u2014 Berenberg downgraded its rating to Sell from Hold with a $27.50 price target.<\/p>\n<p>Northern Trust (NTRS) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $190.00 from $208.00.<\/p>\n<p>Northern Trust (NTRS) \u2014 Capital One Financial set a price target of $190.00; no rating was supplied.<\/p>\n<p>Northrop Grumman (NOC) \u2014 Rothschild &amp; Co Redburn initiated coverage with a Buy rating and a $680.00 price target.<\/p>\n<p>NorthWestern (NWE) \u2014 Barclays maintained its Overweight rating and lowered its price target to $70.00 from $73.00.<\/p>\n<p>Novartis (NVS) \u2014 Morgan Stanley reiterated its Overweight rating and a $156.00 price target.<\/p>\n<p>OceanFirst Financial (OCFC) \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $18.00 from $21.00.<\/p>\n<p>Old National Bancorp (ONB) \u2014 Raymond James upgraded its rating to Outperform from Market Perform with a $29.00 price target.<\/p>\n<p>Old Second Bancorp (OSBC) \u2014 Raymond James upgraded its rating to Strong Buy from Outperform with a $30.00 price target (previous target: $27.00).<\/p>\n<p>Omega Healthcare Investors (OHI) \u2014 Raymond James reiterated its Outperform rating and a $53.00 price target.<\/p>\n<p>OMV (OMVKY) \u2014 RBC Capital Markets upgraded its rating to Sector Perform from Underperform.<\/p>\n<p>OneMain (OMF) \u2014 TD Cowen maintained its Buy rating and lowered its price target to $66.00 from $68.00.<\/p>\n<p>ONEOK (OKE) \u2014 JPMorgan Chase maintained its Neutral rating and lowered its price target to $100.00 from $106.00.<\/p>\n<p>Option Care Health (OPCH) \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p>Ovid Therapeutics (OVID) \u2014 Guggenheim initiated coverage with a Buy rating and a $7 price target.<\/p>\n<p>Owens Corning (OC) \u2014 Barclays maintained its Overweight rating and lowered its price target to $162.00 from $177.00.<\/p>\n<p>Owens Corning (OC) \u2014 Melius Research initiated coverage with a Sell rating and a $118.00 price target.<\/p>\n<p>Pagaya Technologies (PGY) \u2014 TD Cowen maintained its Buy rating and lowered its price target to $25.00 from $26.00.<\/p>\n<p>Parsons (PSN) \u2014 TD Cowen maintained its Buy rating and lowered its price target to $62.00 from $72.00.<\/p>\n<p>PBF Energy (PBF) \u2014 Citigroup maintained its Neutral rating and raised its price target to $91.00 from $74.00.<\/p>\n<p>PENN Entertainment (PENN) \u2014 Deutsche Bank upgraded its rating to Buy from Hold with a $25.00 price target (previous target: $23.00).<\/p>\n<p>Penske Automotive Group (PAG) \u2014 Barclays maintained its Overweight rating and lowered its price target to $210.00 from $225.00.<\/p>\n<p>PepsiCo (PEP) \u2014 RBC Capital Markets maintained its Sector Perform rating and lowered its price target to $150.00 from $161.00.<\/p>\n<p>Personalis (PSNL) \u2014 BTIG Research downgraded its rating to Neutral from Buy.<\/p>\n<p>Personalis (PSNL) \u2014 UBS downgraded its rating to Neutral from Buy.<\/p>\n<p>Pfizer (PFE) \u2014 Scotiabank set a price target of $33.00; no rating was supplied.<\/p>\n<p>Pharvaris (PHVS) \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n<p>Pharvaris (PHVS) \u2014 UBS set a price target of $60.00; no rating was supplied.<\/p>\n<p>PJT Partners (PJT) \u2014 BMO Capital Markets reiterated its Outperform rating.<\/p>\n<p>PJT Partners (PJT) \u2014 Capital One Financial set a price target of $160.00; no rating was supplied.<\/p>\n<p>Praxis Precision Medicines (PRAX) \u2014 BTIG Research maintained its Buy rating and raised its price target to $826.00 from $810.00.<\/p>\n<p>Praxis Precision Medicines (PRAX) \u2014 H.C. Wainwright reiterated its Buy rating and a $1,201.00 price target.<\/p>\n<p>Primis Financial (FRST) \u2014 Raymond James maintained its Strong Buy rating and lowered its price target to $18.00 from $19.00.<\/p>\n<p>Procter &amp; Gamble (PG) \u2014 Evercore upgraded its rating to Outperform from In-line with a $166.00 price target.<\/p>\n<p>Procter &amp; Gamble (PG) \u2014 RBC Capital Markets maintained its Outperform rating and lowered its price target to $166.00 from $167.00.<\/p>\n<p>Prosperity Bancshares (PB) \u2014 Raymond James upgraded its rating to Outperform from Market Perform with a $78.00 price target.<\/p>\n<p>PTC (PTC) \u2014 Citigroup maintained its Market Perform rating and raised its price target to $205.00 from $164.00.<\/p>\n<p>PTC (PTC) \u2014 Mizuho maintained its Neutral rating and raised its price target to $205.00 from $160.00.<\/p>\n<p>Pulse Biosciences (PLSE) \u2014 Canaccord Genuity Group maintained its Buy rating and raised its price target to $58.00 from $43.00.<\/p>\n<p>PulteGroup (PHM) \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $110.00 from $124.00.<\/p>\n<p>PulteGroup (PHM) \u2014 Melius Research initiated coverage with a Hold rating and a $132.00 price target.<\/p>\n<p>Qiagen (QGEN) \u2014 Barclays upgraded its rating to Overweight from Equal Weight with a $55 price target.<\/p>\n<p>QXO (QXO) \u2014 Melius Research initiated coverage with a Buy rating and a $17.00 price target.<\/p>\n<p>Rani Therapeutics (RANI) \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n<p>Rapport Therapeutics (RAPP) \u2014 Guggenheim initiated coverage with a Buy rating and a $65 price target.<\/p>\n<p>Raymond James Financial (RJF) \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $170.00 from $175.00.<\/p>\n<p>RB Global (RBA) \u2014 Barclays maintained its Overweight rating and lowered its price target to $110.00 from $121.00.<\/p>\n<p>Regeneron Pharmaceuticals (REGN) \u2014 JPMorgan Chase maintained its Overweight rating and raised its price target to $950.00 from $900.00.<\/p>\n<p>Revvity (RVTY) \u2014 William Blair initiated coverage with a Outperform rating.<\/p>\n<p>Rexel (RXEEY) \u2014 Morgan Stanley reiterated its Overweight rating.<\/p>\n<p>Rezolute (RZLT) \u2014 Cantor Fitzgerald upgraded its rating to Overweight from Neutral.<\/p>\n<p>Rezolute (RZLT) \u2014 Citigroup reiterated its Outperform rating.<\/p>\n<p>Rezolute (RZLT) \u2014 Citizens Jmp maintained its Market Outperform rating and raised its price target to $15.00 from $11.00.<\/p>\n<p>Rezolute (RZLT) \u2014 Lake Street reiterated its Buy rating and a $12.00 price target.<\/p>\n<p>RH (RH) \u2014 TD Cowen reiterated its Buy rating.<\/p>\n<p>Rio Tinto (RIO) \u2014 RBC Capital Markets upgraded its rating to Sector Perform from Underperform.<\/p>\n<p>Rocket Companies (RKT) \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $13.00 from $15.00.<\/p>\n<p>Rumble (RUM) \u2014 Lake Street initiated coverage with a Hold rating and a $25.00 price target.<\/p>\n<p>RXO (RXO) \u2014 BMO Capital Markets downgraded its rating to Market Perform from Outperform with a $30.25 price target.<\/p>\n<p>RXO (RXO) \u2014 Citigroup maintained its Neutral rating and raised its price target to $30.00 from $23.00.<\/p>\n<p>RXO (RXO) \u2014 Jefferies downgraded its rating to Hold from Buy with a $30.00 price target.<\/p>\n<p>RXO (RXO) \u2014 JPMorgan Chase upgraded its rating to Neutral from Underweight with a $30.00 price target (previous target: $22.00).<\/p>\n<p>RXO (RXO) \u2014 Wells Fargo maintained its Equal Weight rating and raised its price target to $30.00 from $23.00.<\/p>\n<p>Ryan Specialty (RYAN) \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $40.00 from $48.00.<\/p>\n<p>Sandisk (SNDK) \u2014 Mizuho maintained its Outperform rating and raised its price target to $2,050.00 from $1,875.00.<\/p>\n<p>Schneider National (SNDR) \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $35.00 from $38.00.<\/p>\n<p>SentinelOne (S) \u2014 FBN Securities downgraded its rating to Sector Perform from Outperform with a $24.00 price target.<\/p>\n<p>ServiceNow (NOW) \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p>ServiceNow (NOW) \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to $160.00 from $120.00.<\/p>\n<p>ServiceNow (NOW) \u2014 UBS maintained its Neutral rating and raised its price target to $150.00 from $110.00.<\/p>\n<p>ServisFirst Bancshares (SFBS) \u2014 Raymond James downgraded its rating to Outperform from Strong Buy with a $45.00 price target (previous target: $50.00).<\/p>\n<p>Sezzle (SEZL) \u2014 TD Cowen maintained its Buy rating and lowered its price target to $160.00 from $165.00.<\/p>\n<p>Sherwin-Williams (SHW) \u2014 Melius Research initiated coverage with a Hold rating and a $367.00 price target.<\/p>\n<p>Shift4 Payments (FOUR) \u2014 B. Riley Securities maintained its Buy rating and lowered its price target to $94.00 from $96.00.<\/p>\n<p>Shopify (SHOP) \u2014 JPMorgan Chase maintained its Overweight rating and raised its price target to $200.00 from $185.00.<\/p>\n<p>Skyworks Solutions (SWKS) \u2014 B. Riley Securities upgraded its rating to Buy from Neutral with a $107.00 price target (previous target: $68.00).<\/p>\n<p>Skyworks Solutions (SWKS) \u2014 Citigroup maintained its Neutral rating and raised its price target to $90.00 from $64.00.<\/p>\n<p>Snap-On (SNA) \u2014 Barclays set a price target of $435.00; no rating was supplied.<\/p>\n<p>SoFi Technologies (SOFI) \u2014 TD Cowen maintained its Hold rating and lowered its price target to $17.50 from $18.00.<\/p>\n<p>Sol-Gel Technologies (SLGL) \u2014 H.C. Wainwright reiterated its Buy rating.<\/p>\n<p>Sonic Automotive (SAH) \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $75.00 from $87.00.<\/p>\n<p>Southern Copper (SCCO) \u2014 Wells Fargo maintained its Equal Weight rating and raised its price target to $190.00 from $172.00.<\/p>\n<p>Sphere Entertainment (SPHR) \u2014 BTIG Research maintained its Buy rating and lowered its price target to $160.00 from $190.00.<\/p>\n<p>Sphere Entertainment (SPHR) \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n<p>Sphere Entertainment (SPHR) \u2014 Wells Fargo set a price target of $200.00; no rating was supplied.<\/p>\n<p>Sprouts Farmers Market (SFM) \u2014 JPMorgan Chase maintained its Overweight rating and lowered its price target to $90.00 from $103.00.<\/p>\n<p>SPX Technologies (SPXC) \u2014 Robert W. Baird initiated coverage with a Outperform rating and a $220 price target.<\/p>\n<p>Standard Nuclear (STDN) \u2014 CLSA upgraded its rating to Neutral.<\/p>\n<p>Standard Nuclear (STDN) \u2014 Needham initiated coverage with a Buy rating and a $18.00 price target.<\/p>\n<p>Stanley Black &amp; Decker (SWK) \u2014 Morgan Stanley set a price target of $100.00; no rating was supplied.<\/p>\n<p>State Street (STT) \u2014 BMO Capital Markets maintained its Outperform rating and lowered its price target to $200.00 from $212.00.<\/p>\n<p>State Street (STT) \u2014 Capital One Financial set a price target of $200.00; no rating was supplied.<\/p>\n<p>State Street (STT) \u2014 Truist Financial maintained its Hold rating and lowered its price target to $190.00 from $191.00.<\/p>\n<p>Stifel Financial (SF) \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to $75.00 from $85.00.<\/p>\n<p>Stifel Financial (SF) \u2014 Capital One Financial set a price target of $75.00; no rating was supplied.<\/p>\n<p>Stifel Financial (SF) \u2014 JPMorgan Chase maintained its Neutral rating and lowered its price target to $82.00 from $86.00.<\/p>\n<p>Stryker (SYK) \u2014 Truist Financial set a price target of $310.00; no rating was supplied.<\/p>\n<p>Sun Communities (SUI) \u2014 UBS maintained its Neutral rating and lowered its price target to $117.00 from $133.00.<\/p>\n<p>Super Micro Computer (SMCI) \u2014 Mizuho maintained its Neutral rating and raised its price target to $43.00 from $35.00.<\/p>\n<p>Synchrony Financial (SYF) \u2014 TD Cowen maintained its Buy rating and lowered its price target to $86.00 from $90.00.<\/p>\n<p>Taiwan Semiconductor Manufacturing (TSM) \u2014 Barclays maintained its Overweight rating and raised its price target to $665.00 from $650.00.<\/p>\n<p>TE Connectivity (TEL) \u2014 Goldman Sachs maintained its Buy rating and raised its price target to $288.00 from $284.00.<\/p>\n<p>Ternium (TX) \u2014 Wells Fargo maintained its Equal Weight rating and raised its price target to $56.00 from $52.00.<\/p>\n<p>Texas Capital Bancshares (TCBI) \u2014 Raymond James maintained its Outperform rating and lowered its price target to $108.00 from $115.00.<\/p>\n<p>Toll Brothers (TOL) \u2014 Barclays maintained its Underweight rating and lowered its price target to $118.00 from $122.00.<\/p>\n<p>Toll Brothers (TOL) \u2014 Melius Research initiated coverage with a Buy rating and a $179.00 price target.<\/p>\n<p>Trex (TREX) \u2014 Melius Research initiated coverage with a Buy rating and a $62.00 price target.<\/p>\n<p>Tyra Biosciences (TYRA) \u2014 Raymond James reiterated its Strong Buy rating and a $50.00 price target.<\/p>\n<p>U.S. Bancorp (USB) \u2014 Raymond James maintained its Strong Buy rating and lowered its price target to $72.00 from $74.00.<\/p>\n<p>United Airlines (UAL) \u2014 Wells Fargo maintained its Overweight rating and lowered its price target to $160.00 from $165.00.<\/p>\n<p>Upbound Group (UPBD) \u2014 TD Cowen maintained its Buy rating and lowered its price target to $27.00 from $28.00.<\/p>\n<p>Upstart (UPST) \u2014 Needham reiterated its Buy rating and a $42.00 price target.<\/p>\n<p>Valero Energy (VLO) \u2014 Barclays maintained its Overweight rating and raised its price target to $441.00 from $323.00.<\/p>\n<p>Valero Energy (VLO) \u2014 UBS reiterated its Buy rating and a $467.00 price target.<\/p>\n<p>Valley National Bancorp (VLY) \u2014 Keefe, Bruyette &amp; Woods maintained its Market Perform rating and raised its price target to $17.00 from $16.00.<\/p>\n<p>Valvoline (VVV) \u2014 Barclays maintained its Equal Weight rating and lowered its price target to $39.00 from $41.00.<\/p>\n<p>Versigent (VGNT) \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to $58.00 from $59.00.<\/p>\n<p>Vertiv (VRT) \u2014 Glj Research initiated coverage with a Sell rating and a $188.00 price target.<\/p>\n<p>Veru (VERU) \u2014 Westpark Capital initiated coverage with a Buy rating.<\/p>\n<p>Visteon (VC) \u2014 Goldman Sachs maintained its Buy rating and lowered its price target to $104.00 from $126.00.<\/p>\n<p>Voya Financial (VOYA) \u2014 UBS maintained its Buy rating and raised its price target to $127.00 from $125.00.<\/p>\n<p>Vylor (VYLR) \u2014 Oppenheimer initiated coverage with a Outperform rating and a $82 price target.<\/p>\n<p>W.R. Berkley (WRB) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $70.00 from $75.00.<\/p>\n<p>Walt Disney (DIS) \u2014 Sanford C. Bernstein reiterated its Outperform rating.<\/p>\n<p>Wartsila (WRTBY) \u2014 Goldman Sachs upgraded its rating to Buy from Neutral.<\/p>\n<p>Werner Enterprises (WERN) \u2014 Wells Fargo maintained its Equal Weight rating and lowered its price target to $37.00 from $46.00.<\/p>\n<p>WesBanco (WSBC) \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to $45.00 from $46.00.<\/p>\n<p>WesBanco (WSBC) \u2014 Raymond James downgraded its rating to Market Perform from Strong Buy.<\/p>\n<p>Willis Towers Watson Public (WTW) \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to $310.00 from $350.00.<\/p>\n<p>Willis Towers Watson Public (WTW) \u2014 UBS maintained its Buy rating and lowered its price target to $398.00 from $405.00.<\/p>\n<p>Workday (WDAY) \u2014 Citigroup reiterated its Neutral rating.<\/p>\n<p>Worthington Steel (WS) \u2014 KeyCorp reiterated its Overweight rating.<\/p>\n<p>Xenon Pharmaceuticals (XENE) \u2014 Guggenheim resumed coverage with a Buy rating and a $73.00 price target.<\/p>\n<p>Xeris Biopharma (XERS) \u2014 Barclays maintained its Overweight rating and raised its price target to $14.00 from $12.00.<\/p>\n<p>XP (XP) \u2014 Itau BBA upgraded its rating to Outperform from Market Perform with a $27 price target.<\/p>\n<p>Yum! Brands (YUM) \u2014 Guggenheim maintained its Buy rating and lowered its price target to $155.00 from $180.00.<\/p>\n<p>Zai Lab (ZLAB) \u2014 Cantor Fitzgerald reiterated its Overweight rating.<\/p>\n<p>Zeta Global (ZETA) \u2014 DA Davidson maintained its Buy rating and raised its price target to $38.00 from $36.00.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Analyst Ratings (USA) Today\u2019s U.S. analyst updates suggest a selectively bullish but uneven outlook, with higher targets across semiconductors, AI infrastructure and selected software&hellip;<\/p>\n","protected":false},"author":3,"featured_media":72695,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-75988","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v19.4 (Yoast SEO v21.4) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>U.S. Analyst Updates: October 6th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"U.S. Analyst Updates: October 6th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) Today\u2019s U.S. analyst updates suggest a selectively bullish but uneven outlook, with higher targets across semiconductors, AI infrastructure and selected software&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-06T19:54:25+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/03\/Amazon-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1228\" \/>\n\t<meta property=\"og:image:height\" content=\"563\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"26 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"U.S. Analyst Updates: October 6th, 2026\",\"datePublished\":\"2026-10-06T19:54:25+00:00\",\"dateModified\":\"2026-10-06T19:54:25+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/\"},\"wordCount\":5376,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News &amp; Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/\",\"name\":\"U.S. Analyst Updates: October 6th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-06T19:54:25+00:00\",\"dateModified\":\"2026-10-06T19:54:25+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"U.S. Analyst Updates: October 6th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"U.S. Analyst Updates: October 6th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/","og_locale":"en_US","og_type":"article","og_title":"U.S. Analyst Updates: October 6th, 2026","og_description":"Analyst Ratings (USA) Today\u2019s U.S. analyst updates suggest a selectively bullish but uneven outlook, with higher targets across semiconductors, AI infrastructure and selected software&hellip;","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-06T19:54:25+00:00","og_image":[{"width":1228,"height":563,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2026\/03\/Amazon-1.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"26 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"U.S. Analyst Updates: October 6th, 2026","datePublished":"2026-10-06T19:54:25+00:00","dateModified":"2026-10-06T19:54:25+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/"},"wordCount":5376,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News &amp; Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/","name":"U.S. Analyst Updates: October 6th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-06T19:54:25+00:00","dateModified":"2026-10-06T19:54:25+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/u-s-analyst-updates-october-6th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"U.S. Analyst Updates: October 6th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75988","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=75988"}],"version-history":[{"count":3,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75988\/revisions"}],"predecessor-version":[{"id":75996,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/75988\/revisions\/75996"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/72695"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=75988"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=75988"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=75988"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}